Home › Core › ISCC-IDs › 28CrYa2dPfFEf

View ISCC-ID

Core Data

28CrYa2dPfFEf
ISCC-ID - digital asset identifier
CChwjMcsJ8K7H-CTgoMMaRuavUU-CD4N7jENxt6QE-CRKHf8ow7YuvQ
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

cytokine profiles in patients receiving antioxidant therapy within the anticipate trial

Ledger Reference

coblo
Source Ledger/Blockchain
541644
N-th ISCC Decleration on source ledger
5456a7c9f713b50d87835f2f572ca34b9e30a475875dadb6300050bc7710b70f
Hash of block that includes the ISCC-DECLARATION
e84c42a3b9bd64b8d8dd57bda8fede66e445c882974520611cfa79898932172c
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Cytokine profiles in patients receiving antioxidant therapy within the ANTICIPATE trial", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Nehal Shah", "@type": "Person"}], "license": "cc-by-nc", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc3703187?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Baishideng Publishing Group Inc.", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.3748/wjg.v19.i25.4001", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CChwjMcsJ8K7H-CTgoMMaRuavUU-CD4N7jENxt6QE-CRKHf8ow7YuvQ", "propertyID": "ISCC"}], "datePublished": "2013-01-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close